Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04044534

Intranasal Insulin for Posttraumatic Stress Disorder

Conditions: PTSD

Sex: All
Ages: 21 Years – 65 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 10
Sponsor: VA Connecticut Healthcare System

Location: VA Connecticut Healthcare System West Haven Connecticut

Summary

To evaluate if intranasal insulin is effective in reducing PTSD symptoms.

Eligibility Criteria

Inclusion Criteria: * Male or female, 21-65 years old * Current PTSD * Able to provide written informed consent Exclusion Criteria: * Unstable medical condition, clinically determined by a physician * Diabetes requiring insulin or oral hypoglycemic agents * Moderate-severe traumatic brain injury * Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months * Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months * Changes in doses of psychotropic medications in the past 4 weeks * Initiation of individual therapy or counseling in the past 4 weeks * Imminent suicidal or homicidal risk * Contraindication to Insulin * History of claustrophobia * Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04044534). StuddyBuddy aggregates publicly available trial information.